Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2506820
Title:
SYSTÈME MARQUEUR D'ÉVÉNEMENT INGÉRABLE INTÉGRÉ À UN PRODUIT PHARMACEUTIQUE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
108351180
WO application number:
US2010058721
Type:
European patent granted for BE
Status:
Open
Publication number:
2506820
WO publication number:
WO2011068963
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
02/12/2010
Grant date:
18/02/2015
EP publication date:
10/10/2012
WO publication date:
09/06/2011
Claims translation received date:
Translation received date (EP publication B1):
04/05/2015
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
18/02/2015
EP B1 publication date:
18/02/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
02/12/2030
Applicant
1
Name:
Otsuka Pharmaceutical Co., Ltd.
Legal Form:
From:
09/04/2021
Address:
2-9, Kanda Tsukasa-machi
Chiyoda-ku, Tokyo 101-8535, Japan (JP)
To:
2
Name:
Proteus Digital Health, Inc.
Legal Form:
From:
18/02/2015
Address:
2600 Bridge Parkway, Suite 101, Redwood City, CA 94065, United States (US)
To:
09/04/2021
3
Name:
Otsuka America Pharmaceutical, Inc.
Legal Form:
From:
09/04/2021
Address:
2440 Research Boulevard, Rockville, MD 20850, United States (US)
To:
09/04/2021
Agent
1
Name:
DE ZEEUW Rick
Legal Form:
From:
03/11/2022
Address:
Le Fairway,
980 Avenue Roumanille, 06410, BIOT, France (FR)
To:
2
Name:
FYFE Fiona A W
Legal Form:
From:
17/08/2015
Address:
Scotland House Scotland Str 165 169, G5 8PL, GLASGOW, United Kingdom (GB)
To:
01/01/2021
Inventor
1
Name:
HAFEZI, Hooman
Legal Form:
Address:
Redwood City
California 94065, United States (US)
2
Name:
DUCK, Robert
Legal Form:
Address:
San Francisco
California 94106, United States (US)
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws
2
Bulletin heading:
CO
Journal edition number:
2021/13
Publication date:
11/08/2021
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
3
Bulletin heading:
CO
Journal edition number:
2021/13
Publication date:
11/08/2021
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders